Law Meng, Hamburger Micole, Johnson Glyn, Inglese Matilde, Londono Ana, Golfinos John, Zagzag David, Knopp Edmond A
Department of Radiology, NYU Medical Center, MRI Dept., Schwartz Building, Basement HCC, 530 First Avenue, New York, NY 10016, USA.
Technol Cancer Res Treat. 2004 Dec;3(6):557-65. doi: 10.1177/153303460400300605.
Advanced MRI techniques, such as MR spectroscopy, diffusion and perfusion MR imaging can give important in vivo physiological and metabolic information, complementing morphologic findings from conventional MRI in the clinical setting. Combining perfusion MRI and MR spectroscopy can help in patients with brain masses in who the pre-operative differential diagnosis is unclear. This review demonstrates the use of dynamic, susceptibility weighted, contrast-enhanced MR imaging (DSC MRI) and magnetic resonance spectroscopic imaging (MRSI) to distinguish surgical from non-surgical lesions in the brain. There is overlap in the MRI appearance of many enhancing and ring-enhancing lesions such as gliomas, metastases, inflammatory lesions, demyelinating lesions, subacute ischemia, abscess and some AIDS related lesions. We review examples of histopathologically confirmed high-grade glioma, a middle cerebral artery territory infarct, a tumefactive demyelinating lesion and a metastasis for which conventional MR imaging (MRI) was non-specific and potentially misleading and demonstrate how DSC MRI and MRSI features were used to increase the specificity of neurodiagnosis. At several institutions, many patients routinely undergo MRI as well as MRSI and DSC MRI. Cerebral blood flow (CBF), mean transit time (MTT), and relative cerebral blood volume (rCBV) measurements are obtained from regions of maximal perfusion as determined from perfusion color overlay maps. Metabolite levels and ratios are determined for Choline (Cho), N-Acetyl Aspartate (NAA), Lactate and Lipids (LL). Metabolite levels are obtained by measuring the peak heights of each metabolite and the ratios are obtained from these measurements for Cho/Cr, Cho/NAA and NAA/Cr. Neurosurgical intervention carries substantial morbidity, mortality, financial and potential emotional cost to the patient and family. Making a pre-operative diagnosis allows the neurosurgeon to be confident in the choice of treatment plan for the patient and allays considerable patient anxiety. The utility of combining clinical findings with multi-parametric information from perfusion and spectroscopic MR imaging in differentiating surgical lesions from those which do not require surgical intervention is discussed.
先进的磁共振成像(MRI)技术,如磁共振波谱分析、扩散加权成像和灌注加权成像,能够提供重要的体内生理和代谢信息,在临床环境中补充传统MRI的形态学发现。对于术前鉴别诊断不明确的脑肿瘤患者,联合灌注MRI和磁共振波谱分析可能会有所帮助。本综述展示了利用动态磁敏感加权对比增强磁共振成像(DSC MRI)和磁共振波谱成像(MRSI)来区分脑部手术性病变和非手术性病变。许多强化和环形强化病变,如胶质瘤、转移瘤、炎症性病变、脱髓鞘病变、亚急性缺血、脓肿以及一些与艾滋病相关的病变,在MRI表现上存在重叠。我们回顾了组织病理学确诊的高级别胶质瘤、大脑中动脉供血区梗死、瘤样脱髓鞘病变和转移瘤的病例,这些病例中传统磁共振成像(MRI)表现不具有特异性且可能产生误导,并展示了如何利用DSC MRI和MRSI特征来提高神经诊断的特异性。在多个机构中,许多患者常规接受MRI以及MRSI和DSC MRI检查。从灌注彩色叠加图确定的最大灌注区域获取脑血流量(CBF)、平均通过时间(MTT)和相对脑血容量(rCBV)测量值。测定胆碱(Cho)、N-乙酰天门冬氨酸(NAA)、乳酸和脂质(LL)的代谢物水平及比率。通过测量每种代谢物峰高获得代谢物水平,通过这些测量值计算Cho/Cr、Cho/NAA和NAA/Cr比率。神经外科手术对患者及其家属具有较高的发病率、死亡率、经济负担和潜在的情感成本。术前做出诊断可使神经外科医生对患者的治疗方案选择充满信心,并减轻患者的巨大焦虑。本文讨论了将临床发现与灌注和波谱磁共振成像的多参数信息相结合,在区分手术性病变和无需手术干预的病变方面的实用性。